Tirbanibulin

Drug Overview

Tirbanibulin is a specialized, prescription-strength medication used in dermatology and cancer prevention. It is not a traditional pill or a liquid injection. Instead, it is an ointment that is applied directly to the skin. It is designed to treat spots on the skin caused by years of sun damage. These spots are called actinic keratosis (AK). If left untreated, these rough skin patches can sometimes turn into a type of skin cancer called squamous cell carcinoma.

Tirbanibulin is a modern Targeted Therapy. It goes straight to the damaged cells to stop them from growing, helping the skin heal before cancer can fully develop.

Here are the key details about this medication:

• Generic Name: Tirbanibulin
• US Brand Names: Klisyri®
• Drug Class: Microtubule Inhibitor / Antiproliferant (Targeted Therapy)
• Route of Administration: Topical (Ointment applied onto the skin)
• FDA Approval Status: FDA-approved. It was originally approved in December 2020 for public use in the United States. In 2024, the FDA expanded its approval, allowing it to be used on larger areas of sun-damaged skin.

What Is It and How Does It Work? (Mechanism of Action)

To understand how tirbanibulin works, it helps to know what happens inside a sun-damaged skin cell. When skin is exposed to too much ultraviolet (UV) light over a lifetime, the cells’ DNA gets damaged. This damage causes the skin cells to multiply too fast, creating rough, scaly precancerous patches.

Tirbanibulin is designed as a Targeted Therapy to act directly on these fast-growing cells. It works through a dual-action process at the microscopic, molecular level:

1. Entering the Skin Cells: Once the ointment is rubbed onto the rough patch, the medicine sinks into the top layers of the skin and enters the damaged cells.
2. The Microtubule Blocker: Inside every cell, there are tiny tubes called microtubules. Cells need these tubes to pull themselves apart and divide into new cells. Tirbanibulin blocks a building block called tubulin. Without tubulin, the microtubules fall apart. Because the cell cannot divide, it stops growing. This is called “cell cycle arrest.”
3. The Signal Jammer (Src Kinase Inhibition): Fast-growing precancerous cells rely on a specific alarm system, a protein called Src kinase, to tell them to survive and multiply. Tirbanibulin blocks this Src kinase signal. It acts like a signal jammer, cutting off the bad cell’s communication.
4. Clearing the Bad Cells: Because the damaged cell cannot divide and has lost its survival signals, it safely dies off in a natural process called apoptosis. The body then clears away the dead cells, leaving room for new, healthy skin to grow.

FDA-Approved Clinical Indications

Tirbanibulin is currently approved by official health agencies for specific uses.

• Oncological / Pre-cancerous Uses:
  • Actinic Keratosis (AK) of the Face or Scalp: It is approved for the topical treatment of these precancerous skin lesions. By clearing these spots, the drug helps prevent them from developing into invasive squamous cell skin cancer.
• Non-oncological Uses:
  • Currently, there are no FDA-approved non-oncological uses for this medication. It is strictly used for sun-damaged, precancerous skin.

Dosage and Administration Protocols

Because tirbanibulin is a targeted skin treatment, it is applied for a very short period of time compared to older skin creams. It comes in small, single-use packets.

Clinical Efficacy and Research Results

Recent clinical studies between 2020 and 2025 have shown that tirbanibulin is highly effective and well-liked by patients. Major real-world studies, such as the PROAK and KLIR studies published recently, highlight its success:

• High Clearance Rates: Studies show that about 70% to 74% of patients using tirbanibulin achieved complete or partial clearance of their precancerous lesions within two months. Partial clearance means that the size and number of the rough patches shrank by at least 75%.
• Reduction in Lesions: In a large 2025 European study, patients saw their average number of actinic keratosis spots drop by 70% after just one 5-day treatment cycle.
• Preventing Disease Progression: By successfully clearing these rough patches, the treatment stops the disease from getting worse. It lowers the risk of the spots turning into dangerous skin cancer.
• Patient Satisfaction: According to the 2025 medical conferences, over 90% of patients reported that their skin looked and felt much better. Patients strongly prefer this medication because it only takes 5 days to use, while older creams often take 4 to 6 weeks of daily use.

Safety Profile and Side Effects

Black Box Warning: There is NO FDA Black Box Warning for this medication.

Because tirbanibulin is applied locally to the skin, it does not cause the heavy side effects seen with traditional cancer pills or IV treatments. However, because it works by killing damaged cells, some skin reactions are expected.

Common Side Effects (>10%)

• Redness (Erythema): The treated skin often turns red. This is a sign that the medicine is working to destroy the bad cells.
• Flaking and Scaling: As the bad cells die, the skin will peel or flake off.
• Crusting and Swelling: Mild scabs or puffiness can occur in the treated area.
• Application Site Pain: Mild itching, stinging, or tenderness where the ointment was rubbed in.

Serious Adverse Events

• Severe Skin Reactions (Rare): In some cases, the skin can develop painful ulcers, deep sores, or severe blisters (pustules).
• Eye Irritation: If the medicine is accidentally rubbed into the eyes, it can cause severe irritation and pain.

Management Strategies

• For Normal Flaking and Redness: Keep the area clean. Do not pick at the scabs or peeling skin. Let it heal naturally.
• For Severe Blisters or Sores: Stop using the ointment immediately and contact your healthcare provider.
• For Eye Exposure: If the ointment gets into your eyes, flush them immediately with plenty of water and seek emergency medical care.

Research Areas

While tirbanibulin is currently only approved for the face and scalp, scientists are actively researching new ways to use it. Current studies are exploring its effectiveness on other parts of the body that get a lot of sun, such as the arms, hands, and chest. Researchers are also looking into whether its powerful “microtubule blocking” ability could help treat other skin diseases where cells grow out of control.

Patient Management and Practical Recommendations

To make sure the treatment works well and is as safe as possible, patients should follow a few clear rules.

Pre-treatment Tests to be Performed

• Visual Skin Examination: A dermatologist must look closely at the spots to confirm they are actinic keratosis. If a spot looks like it has already turned into full skin cancer, a biopsy (taking a tiny skin sample) might be needed instead of the ointment.
• Skin Health Check: The doctor will check to ensure the skin is not currently cut, infected, or recovering from a recent surgery.

Precautions During Treatment

• Avoid getting the medicine on your lips, inside your nose, or near your eyes.
• Do not cover the treated area with bandages or tight wrappings. Letting the skin breathe is important.

“Do’s and Don’ts” List

• DO wash your hands with soap and water immediately after putting the ointment on your skin.
• DO wait at least 8 hours before washing the treated area or touching it. After 8 hours, you can gently wash the area with mild soap and water.
• DO throw away the medicine packet after one use, even if there is some left inside.
• DON’T apply the medicine more than once a day. More medicine will not make it work faster, but it will cause worse side effects.
• DON’T go out into harsh sunlight or use tanning beds while using this medicine. Always wear a wide-brimmed hat when you step outside.
• DON’T let other people or pets touch your treated skin for at least 8 hours. If they do accidentally touch it, they should wash their skin right away.

Legal Disclaimer

The information provided in this guide is for educational and informational purposes only. It does not take the place of professional medical advice, diagnosis, or treatment. Always talk to your doctor, dermatologist, or qualified healthcare provider with any questions you may have regarding a medical condition or treatment plan. Never ignore professional medical advice or delay in seeking it because of something you have read in this guide.